The original shielding letters and advice that have been sent out to people who are highly vulnerable to COVID-19 (coronavirus) infection stated that all recipients of the letter should completely isolate themselves from physical contact, not go outside of their homes for 12 weeks.
This advice was sent to all patients of the National Aspergillosis Centre (NAC) who have chronic pulmonary aspergillosis (CPA).
Patients who have allergic bronchopulmonary aspergillosis (ABPA), severe asthma and forms of aspergillosis other than CPA were informed of their vulnerability status by their local respiratory clinic or GP. Some will have been told to shield, others not but all shielding advice was to remain in place for 12 weeks from the day of receipt of the letter.
That advice for people shielding has now been amended to say that all shielding people should continue shielding until the end of June 2020.
Latest advice from Welsh government
Share this post
Latest News posts
Thinking about joining a clinical trial? What are your concerns?
December 12, 2024
Biologics & ABPA – what are they and what can they do?
October 19, 2024
UK National RSV vaccination program launched
July 26, 2024
English prescription charge to rise 1st May 2024
April 26, 2024
The Role of Speech & Language Therapy (SALT)
April 16, 2024
Understanding How Our Lungs Fight Fungus
April 15, 2024
Chronic illness diagnosis and guilt
April 12, 2024
News archive
- Antifungals in development
- COVID-19
- Events
- Fundraising
- General interest
- How do I...?
- Information and Learning
- Latest research news
- Lifestyle and Coping Skills
- Living with Aspergillosis
- NAC announcements
- News archive
- Patient and Carer Blog
- Patient stories
- Recordings
- Supplements and complementary therapies
- Types of aspergillosis
- Video